Cel-Sci
CVM
#9766
Rank
$51.55 M
Marketcap
$6.45
Share price
2.54%
Change (1 day)
-61.61%
Change (1 year)

Cel-Sci (CVM) - Total debt

Total debt on the balance sheet as of June 2025 : $9.96 Million USD

According to Cel-Sci 's latest financial reports the company's total debt is $9.96 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Cel-Sci - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-09-30$11.62 M-14.37%
2023-09-30$13.57 M-11.31%
2022-09-30$15.3 M-4.19%
2021-09-30$15.97 M14.6%
2020-09-30$13.93 M3.18%
2019-09-30$13.5 M0.96%
2018-09-30$13.37 M-5.82%
2017-09-30$14.2 M9.19%
2016-09-30$13.01 M-6.31%
2015-09-30$13.88 M1138.19%
2014-09-30$1.12 M-1.02%
2013-09-30$1.13 M2.64%
2012-09-30$1.1 M-77.91%
2011-09-30$4.99 M352.78%
2010-09-30$1.1 M-0.3%
2009-09-30$1.1 M453.67%
2008-09-30$0.2 M
2005-09-30$0 M0%
2004-09-30$0 M-99.66%
2003-09-30$0.87 M-50.78%
2002-09-30$1.77 M5583.6%
2001-09-30$0.03 M25.77%
2000-09-30$0.02 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Curis
CRIS
$1.96 M-80.25%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
$0.64 B 6,377.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$54.58 B 547,746.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
$69.26 M 595.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$17.07 B 171,248.22%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
$45.79 B 459,508.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$0.66 B 6,555.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
$0.55 M-94.46%๐Ÿ‡บ๐Ÿ‡ธ USA